Klin Farmakol Farm. 2017;31(1):19-21 | DOI: 10.36290/far.2017.005

Alveolar echinococcosis – life-threatening disease

Petr Husa ml.1, 2, Matúš Mihalčin1, 2, Petr Husa1, 2
Klinika infekčních chorob Fakultní nemocnice Brno; 1
Lékařská fakulta Masarykovy univerzity, Brno; 2

Alveolar echinococcosis (AE) is serious parasitic disease imitating malignant tumors with its appearance and growth. AE is caused by small tapeworm called Echinococcus multilocularis (EM) with is living in gastrointestinal tract of carnivores. Early diagnostic and radical surgical excision in combination with long-term chemotherapy may completely eradicate the parasites and cure the patient. Untreated disease has mortality rate more than 90 % within 10–15 years. Echinococcosis is very rare disease in the Czech Republic. Only few cases are diagnosed each year. However with increasing distribution and prevalence of EM in European population of foxes, the number of human cases will probably rise in the coming years.

Keywords: alveolar echinococcosis, Echinococcus multilocularis, alveococcosis, albendazol, mebendazol.

Published: May 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P, Mihalčin M, Husa P. Alveolar echinococcosis – life-threatening disease. Klin Farmakol Farm. 2017;31(1):19-21. doi: 10.36290/far.2017.005.
Download citation

References

  1. Kolářová L, Stejskal F. Hydatóza cystická a alveolární (multilokulární). In: Echinokokové infekce. Praha 3.4 2014: sborník příspěvků konference, [online], [cit. 2017-03-08], Dostupné z http://www.parazitologie.cz/akce/doc/sbornik/2014%20seminar%20v%20LD_Hydatidoza.pdf.
  2. Beneš J, et al. Echinokokóza (hydatóza) multilokulární, alveokokóza. In: Infekční lékařství. Praha, Galén 2008: 360-361.
  3. Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bull World Health Organ 1996; 74(3): 231-242. Go to PubMed...
  4. Sréter, et al. Echinococcus multilocularis: An Emerging Pathogen in Hungary and Central Eastern Europe - Volume 9, Number 3-March 2003 - Emerging Infectious Disease journal - CDC. Go to original source... Go to PubMed...
  5. Prevention C-C for DC and. CDC - Echinococcosis - Epidemiology & Risk Factors,, [online], [cit. 2017-03-08], Dostupné z http://www.cdc.gov/parasites/echinococcosis/epi.html.
  6. Torgerson PR, Keller K, Magnotta M, Ragland N. The Global Burden of Alveolar Echinococcosis. PLoS Negl Trop Dis 2010; 4(6). Go to original source...
  7. Wang Z, Wang X, Liu X. Echinococcosis in China, a review of the epidemiology of Echinococcus spp. EcoHealth 2008; 5(2): 115-126. Go to original source... Go to PubMed...
  8. Umhang G, Comte S, Hormaz V, Boucher J-M, Raton V, Favier S, et al. Retrospective analyses of fox feces by real-time PCR to identify new endemic areas of Echinococcus multi-locularis in France. Parasitol Res 2016; 115(11): 4437-4441. Go to original source... Go to PubMed...
  9. Vybrané infekční nemoci v ČR v letech 2006-2015 - absolutně, SZÚ, [online], [cit. 2017-03-08], Dostupné z http://www.szu.cz/publikace/data/vybrane-infekcni-nemoci-v-cr-v-letech-2006-2015-absolutne.
  10. Svobodová V. Výskyt tasemnic rodu Echinococcus u zvířat v České republice. In: Echinokokové infekce. Praha: 2014.
  11. Lass A, Szostakowska B, Myjak P, Korzeniewski K. Fresh fruits, vegetables and mushrooms as transmission vehicles for Echinococcus multilocularis in highly endemic areas of Poland: reply to concerns. Parasitol Res 2016; 115(9): 3637-3642. Go to original source... Go to PubMed...
  12. Prevention C-C for DC and. CDC - Echinococcosis - Biology, [online], [cit. 2017-03-08], Dostupné z http://www.cdc.gov/parasites/echinococcosis/biology.html.
  13. Mills CL DVM. Echinococcus. Salem Press Encycl Health 2016.
  14. Eckert J, Deplazes P. Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing Concern. Clin Microbiol Rev 2004; 17(1): 107-135. Go to original source... Go to PubMed...
  15. Stumpe KDM, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien P-A, et al. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 2007; 35(1): 11-18. Go to original source... Go to PubMed...
  16. Aydinli B, Ozturk G, Arslan S, Kantarci M, Tan O, Ah?skalioglu A, et al. Liver transplantation for alveolar echinococcosis in an endemic region. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 2015; 21(8): 1096-1102. Go to original source... Go to PubMed...
  17. Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 2000; 46(3): 451-456. Go to original source... Go to PubMed...
  18. Ammann RW, Fleiner-Hoffmann A, Grimm F, Eckert J. Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis. J Hepatol 1998; 29(6): 994-998. Go to original source... Go to PubMed...
  19. Ammann R, Tschudi K, von Ziegler M, Meister F, Cotting J, Eckert J, et al. [The long-term course of 60 patients with alveolar echinococcosis in continuous therapy with mebendazole (1976-85)]. Klin Wochenschr 1988; 66(21): 1060-1073. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.